HMG-CoA Reductase Inhibitors: Do They Have Potential in the Treatment of Polycystic Ovary Syndrome?

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.13, 2008-01, pp. : 1771-1785

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HMG-CoA Reductase Inhibitors in Osteoporosis: Do They Reduce the Risk of Fracture?

By Schlienger R.G. Meier C.R.

Drugs & Aging, Vol. 20, Iss. 5, 2003-01 ,pp. : 321-336

Adis International

Access to resources Recommend Favorite

Effects of HMG-CoA Reductase Inhibitors on Skeletal Muscle: Are all Statins the Same?

By Evans M. Rees A.

Drug Safety, Vol. 25, Iss. 9, 2002-01 ,pp. : 649-663

Adis International

Access to resources Recommend Favorite

Who Should Receive HMG CoA Reductase Inhibitors?

By Teo K.K.

Drugs, Vol. 62, Iss. 12, 2002-01 ,pp. : 1707-1715

Adis International

Access to resources Recommend Favorite

Secondary Prevention of Coronary Heart Disease in Elderly Patients Following Myocardial Infarction: Are All HMG-CoA Reductase Inhibitors Alike?

By Maroo Bijesh P. Lavie Carl J. Milani Richard V.

Drugs & Aging, Vol. 25, Iss. 8, 2008-01 ,pp. : 649-664

Adis International

Access to resources Recommend Favorite

How Do HMG-CoA Reductase Inhibitors Prevent Stroke?

By Bedi A.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 1, 2002-01 ,pp. : 7-14

Adis International

Access to resources Recommend Favorite